- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03352362
Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children
There are difficulties in the progress of the study and cancel the plan. The purpose of this study is to evaluate the postoperative pain control using non - opioidal analgesics in children. The investigators will investigate the effect of single use and combination of caldorol(ibuprofen) compare to denogan(propacetamol) in children.
Participants who receive the laparoscopic inguinal hernia repair between 6 months and 6 years old are divided 3 groups(caldolor, denogan, combination). Each groups are received a medication by protocol during surgery. After operation patient's pain score and use of additional analgesics are recorded in postanesthesia care unit and general ward.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 03722
- Department of Anesthesiology and Pain MedicineYonsei University College of Medicine Severance Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- scheduled to undergo laparoscopic inguinal hernia surgery
- American Society of Anesthesiologists physical status classification 1 or 2
- Children aged 6 months to 6 years
Exclusion Criteria:
- history of Gastrointestinal bleeding
- history or laboratory finding of suspected renal or hepatic dysfunction
- bronchial asthma
- bleeding disorder
- hypersensitivity to NSAID or propacetamol
- disagreement of investigation
- The researcher determines that participation is inappropriate due to other reasons.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: caldolor
intravenous caldolor injection during intraoperative period
|
Dilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia
|
Active Comparator: denogan
intravenous denogan injection during intraoperative period
|
Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end
|
Experimental: combination
intravenous denogan and caldolor injection during intraoperative period
|
Dilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
additional administration of analgesics
Time Frame: during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour
|
whether additional analgesics are administered during the postanesthesia care unit due to pain
|
during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain score (FLACC)
Time Frame: Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)
|
Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain.
The scale is scored in a range of 0-10 with 0 representing no pain.
The scale has five criteria, which are each assigned a score of 0, 1 or 2.
|
Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)
|
pain score (FLACC)
Time Frame: Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)
|
Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain.
The scale is scored in a range of 0-10 with 0 representing no pain.
The scale has five criteria, which are each assigned a score of 0, 1 or 2.
|
Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)
|
pain score (FLACC)
Time Frame: Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)
|
Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain.
The scale is scored in a range of 0-10 with 0 representing no pain.
The scale has five criteria, which are each assigned a score of 0, 1 or 2.
|
Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)
|
pain score (FLACC)
Time Frame: Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)
|
Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain.
The scale is scored in a range of 0-10 with 0 representing no pain.
The scale has five criteria, which are each assigned a score of 0, 1 or 2.
|
Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)
|
pain score (CHEOPS)
Time Frame: Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)
|
Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years.
It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort.
It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).
|
Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)
|
pain score (CHEOPS)
Time Frame: Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)
|
Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years.
It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort.
It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).
|
Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)
|
pain score (CHEOPS)
Time Frame: Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)
|
Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years.
It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort.
It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).
|
Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)
|
pain score (CHEOPS)
Time Frame: Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)
|
Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years.
It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort.
It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).
|
Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)
|
pain score (PPPM scale)
Time Frame: The PPPM scale is measured at 4 hours after surgery
|
Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15.
A score of at least 6 out of 15 signifies clinically significant pain.
|
The PPPM scale is measured at 4 hours after surgery
|
pain score (PPPM scale)
Time Frame: The PPPM scale is measured at 12 hours after surgery
|
Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15.
A score of at least 6 out of 15 signifies clinically significant pain.
|
The PPPM scale is measured at 12 hours after surgery
|
pain score (PPPM scale)
Time Frame: The PPPM scale is measured at 24 hours after surgery
|
Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15.
A score of at least 6 out of 15 signifies clinically significant pain.
|
The PPPM scale is measured at 24 hours after surgery
|
incidence of complications
Time Frame: during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour
|
incidence of complications in PACU (postanesthesia care unit)
|
during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pathological Conditions, Anatomical
- Hernia, Abdominal
- Pain, Postoperative
- Hernia
- Hernia, Inguinal
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antipyretics
- Acetaminophen
- Ibuprofen
- Propacetamol
Other Study ID Numbers
- 4-2017-0869
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inguinal Hernia
-
Children's Mercy Hospital Kansas CityRecruitingInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalEnrolling by invitationInguinal Hernia | Strangulated Inguinal Hernia | Incarcerated Inguinal HerniaTurkey
-
University Hospital, GhentMedriCompleted
-
Ahmadullah DanishCompletedIncarcerated Inguinal HerniaAfghanistan
-
General Hospital of LarissaUnknown
-
Alexandria UniversityCompletedBilateral Inguinal Hernia
-
Hospital Siberia-SerenaUnknownPrimary Inguinal HerniaSpain
-
Diskapi Teaching and Research HospitalCompleted
Clinical Trials on ibuprofen (caldolor 10 mg / kg)
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
MedImmune LLCCompletedRelapsed/Refractory Aggressive B-cell LymphomasUnited States
-
Eisai Co., Ltd.Completed
-
MedImmune LLCCompletedHealthy SubjectsUnited States
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
Firas El Chaer, MDRecruitingHematologic Malignancy | Platelet RefractorinessUnited States
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedGastric/Gastroesophageal Junction CancerChina
-
ReAlta Life Sciences, Inc.WithdrawnCOVID-19 | Acute Lung Injury | ALIUnited States
-
Novartis PharmaceuticalsCompleted
-
RezoluteRecruitingCongenital HyperinsulinismBulgaria, Canada, Denmark, France, Georgia, Germany, Greece, Israel, Oman, Qatar, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom, Vietnam